Sanochemia’s plant in Neufeld an der Leitha (Burgenland) produces active pharmaceutical ingredients (APIs) both for the company's own requirements and for third parties. The Neufeld plant manufactures finished products for the human field.
The company's industrial competence and state-of-the-art development and production facilities enable it to comply with relevant Current Good Manufacturing Practice (cGMP) requirements in production, packaging and analysis. Its plants constantly adopt the latest technology. Quality and drug safety are high priorities. At Sanochemia, complete documentation is a matter of course in the manufacturing process and this ensures the safe and reproducible quality of the group’s products.
Sanochemia develops and produces active pharmaceutical ingredients (APIs) in its Active Ingredient Synthesis segment. Its activities range from the development of a laboratory process to upscaling to production on an industrial scale, and it combines all this under one roof. It has established modern in-house development and release analytics, and regulatory support for the preparation of approval documents to facilitate this. Many years of experience and the best technical equipment enable Sanochemia to offer other pharmaceutical companies services in the development of highly complex active pharmaceutical ingredients.
Sanochemia specialises in the manufacture of pharmaceuticals in solid, liquid, semi-solid and injectable dosage forms. It processes and packages both sterile and low-germ products in accordance with GMP standards. Its pharmaceutical production lines can be used to manufacture high-quality pharmaceutical products. Most of the imaging agents and pharmaceuticals which it sells are manufactured at its Neufeld an der Leitha plant. Through its targeted expansion of pharmaceutical production, Sanochemia has achieved the improvements and expansion required to establish a new, high-performance pharmaceutical production line.
©2020 SANOCHEMIA Pharmazeutika GmbH. All rights reserved.